208 related articles for article (PubMed ID: 5143131)
41. [Treatment of malignant lymphoma].
Maurice PA
Schweiz Med Wochenschr; 1971 Oct; 101(42):1516-9. PubMed ID: 5143016
[No Abstract] [Full Text] [Related]
42. [Life expectancy in Hodgkin's disease].
Bernadou A; Bousser J
Rev Prat; 1974 Oct; 24(45):3999-4002. PubMed ID: 4445769
[No Abstract] [Full Text] [Related]
43. [Chemotherapy of Hodgkin's disease].
Schneider M
Radiol Clin Biol; 1966; 35(3):141-52. PubMed ID: 5965075
[No Abstract] [Full Text] [Related]
44. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
45. [On the treatment of lymphogranuloma].
Hammer B
Wien Med Wochenschr; 1966 Jun; 116(25):562-5. PubMed ID: 5995246
[No Abstract] [Full Text] [Related]
46. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
Hollard D; Schaerrer R
Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371
[No Abstract] [Full Text] [Related]
47. Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease.
Raina V; Sharma A; Mohanti BK; Kumar R; Dawar R; Rath GK
Natl Med J India; 2003; 16(4):199-203. PubMed ID: 14606767
[TBL] [Abstract][Full Text] [Related]
48. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
49. [Hodgkin's disease. Treatment of localized forms I and II using a combination of radiotherapy and chemotherapy].
Teillet F; Weisgerber C; Dana M; Feingold N; Chelloul N; Thiebaud F; Jacquillat C; Boiron M; Bernard J
Nouv Presse Med; 1974 Sep; 3(31):1925-8. PubMed ID: 4216881
[No Abstract] [Full Text] [Related]
50. [Choice of therapeutic methods during the 3d stage of Hodgkin's disease].
Mazurowa A; Płuzańska A; Dmochowska M; Krykowski E; Fajndt S; Studencki E; Zadrozna O
Pol Tyg Lek; 1978 Jul; 33(27):1073-5. PubMed ID: 693381
[No Abstract] [Full Text] [Related]
51. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
52. [Diagnosis and therapy of Hodgkin's disease].
Huhn D; Heinze HG; Steidle C
Munch Med Wochenschr; 1973 May; 115(19):865-77. PubMed ID: 4200410
[No Abstract] [Full Text] [Related]
53. [Treatment of Hodgkin's disease with Natulan].
Anglesio E
Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
[No Abstract] [Full Text] [Related]
54. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Bishop RC
Radiol Clin North Am; 1968 Apr; 6(1):91-5. PubMed ID: 5652936
[No Abstract] [Full Text] [Related]
56. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
da Silva MP; Kerbauy J; de Guerra CC
Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
[No Abstract] [Full Text] [Related]
57. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy.
Lacher MJ
Prog Clin Cancer; 1982; 8():283-97. PubMed ID: 7156405
[No Abstract] [Full Text] [Related]
58. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Bonadonna G
Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
[TBL] [Abstract][Full Text] [Related]
59. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
Weh HJ; Andrieu JM
MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
[TBL] [Abstract][Full Text] [Related]
60. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
